Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | EVP and CLO | May 11, 2012 | May 14, 2012 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date May 11, 2012 · Filed May 14, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 214.1895 |
Ending reported balance
After 2012-05-11 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2012-05-11 · Exercise / conversion · Acquired 35,043 · Balance 35,257.1895 Row 2 · 2012-05-11 · Sale · Disposed 35,043 · Balance 214.1895 F1: All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $46.17 and $46.18 per share. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $41.17 · Expires 2015-04-01 | Direct | 0 |
Reported balance
After 2012-05-11 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2012-05-11 · Exercise / conversion · Disposed 35,043 · Balance 0 F3: Option became exercisable in three equal annual installments, commencing 4/1/2009. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $28.10 · Expires 2016-04-01 | Direct | 0 |
Reported balance
Holding disclosure · report date 2012-05-11 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 0 F4: Option became exercisable in three equal annual installments, commencing 4/1/2010. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $34.96 · Expires 2018-04-01 | Direct | 70,336 |
Reported balance
Holding disclosure · report date 2012-05-11 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 70,336 F5: Option becomes exercisable in four equal annual installments, commencing 4/1/2012. |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 91,382 |
Reported balance
Holding disclosure · report date 2012-05-11 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 91,382 |
| ESOP Common StockSEC Table I · non-derivative | IndirectBy ESOP | 2,211.8523 |
Reported balance
Holding disclosure · report date 2012-05-11 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 2,211.8523 |
| Stock UnitSEC Table I · non-derivative | Direct | 14,681 |
Reported balance
Holding disclosure · report date 2012-05-11 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 14,681 |
Filing footnotes · ownership attribution and instrument terms
F1: All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $46.17 and $46.18 per share.
F3: Option became exercisable in three equal annual installments, commencing 4/1/2009.
F4: Option became exercisable in three equal annual installments, commencing 4/1/2010.
F5: Option becomes exercisable in four equal annual installments, commencing 4/1/2012.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 08, 2004 Filed Jan 12, 2004 20:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 35,000 | $0.00 Strike: $35.34 | $0.00 |
DisclosureSEC source: 0001194416-04-000005 · c0001194417d20040112f4f.xml · derivative · entry 5 SGARRO DOUGLAS A · CIK 0001194417 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2011-01-08 F1 · derivative.exercise_date: Options become exercisable in three equal annual installments, commencing 01/08/2005. Read SEC document |
| January 08, 2004 Filed Jan 12, 2004 20:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001194416-04-000005 · c0001194417d20040112f4f.xml · nonDerivative · entry 1 SGARRO DOUGLAS A · CIK 0001194417 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,508 Read SEC document |
| December 31, 2003 Filed Feb 10, 2004 16:06 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantPhantom Stock Credits · Derivative | 1,018 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001194405-04-000006 · c0001194417d20040210f5f.xml · derivative · entry 5 SGARRO DOUGLAS A · CIK 0001194417 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,018 Underlying: Common Stock · 1,018 shares Expires not disclosed F4 · derivative.exercise_price: Each share credit is equivalent to one share; 1-for-1 conversion. F5 · shares: Reflects 2001, 2002 and 2003 year end company match share credits of 442, 55 and 521, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. F5 · derivative.exercise_date: Reflects 2001, 2002 and 2003 year end company match share credits of 442, 55 and 521, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. F5 · derivative.expiration_date: Reflects 2001, 2002 and 2003 year end company match share credits of 442, 55 and 521, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.